Endolaser treatment of the ciliary body for severe glaucoma

M. A. Zarbin, R. G. Michels, S. De Bustros, Harry A Quigley, A. Patel

Research output: Contribution to journalArticle

Abstract

Endolaser photocoagulation of the ciliary body was used to treat 42 eyes with severe glaucoma that could not be managed successfully by medical therapy and conventional glaucoma surgery. Follow-up ranged from 6 to 36 months (mean, 13 months). The preoperative intraocular pressure (IOP) ranged from 13 to 76 mmHg (mean, 37 mmHg). The postoperative IOP ranged from 1 to 44 mmHg (mean, 17 mmHg), representing an absolute decrease of 20 mmHg, and a mean decrease of 48%. After one or two (7 eyes) treatment sessions, 11 eyes (26%) had an IOP less than 21 mmHg without medications; 21 eyes (50%) had an IOP less than 21 mmHg with medications; 5 eyes (12%) had an IOP of 21 to 25 mmHg with or without medications; and 5 eyes (12%) had an IOP greater than 25 mmHg. Postoperatively, the number of antiglaucoma medications required was reduced from a mean of 2.8 ± 0.13 to a mean of 1.4 ± 0.19. Twenty-three (72%) of 32 patients were able to discontinue carbonic anhydrase inhibitors.

Original languageEnglish (US)
Pages (from-to)1639-1648
Number of pages10
JournalOphthalmology
Volume95
Issue number12
StatePublished - 1988

Fingerprint

Ciliary Body
Intraocular Pressure
Glaucoma
Therapeutics
Carbonic Anhydrase Inhibitors
Light Coagulation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Zarbin, M. A., Michels, R. G., De Bustros, S., Quigley, H. A., & Patel, A. (1988). Endolaser treatment of the ciliary body for severe glaucoma. Ophthalmology, 95(12), 1639-1648.

Endolaser treatment of the ciliary body for severe glaucoma. / Zarbin, M. A.; Michels, R. G.; De Bustros, S.; Quigley, Harry A; Patel, A.

In: Ophthalmology, Vol. 95, No. 12, 1988, p. 1639-1648.

Research output: Contribution to journalArticle

Zarbin, MA, Michels, RG, De Bustros, S, Quigley, HA & Patel, A 1988, 'Endolaser treatment of the ciliary body for severe glaucoma', Ophthalmology, vol. 95, no. 12, pp. 1639-1648.
Zarbin MA, Michels RG, De Bustros S, Quigley HA, Patel A. Endolaser treatment of the ciliary body for severe glaucoma. Ophthalmology. 1988;95(12):1639-1648.
Zarbin, M. A. ; Michels, R. G. ; De Bustros, S. ; Quigley, Harry A ; Patel, A. / Endolaser treatment of the ciliary body for severe glaucoma. In: Ophthalmology. 1988 ; Vol. 95, No. 12. pp. 1639-1648.
@article{d9b9f6758c4d438db743358ab895e133,
title = "Endolaser treatment of the ciliary body for severe glaucoma",
abstract = "Endolaser photocoagulation of the ciliary body was used to treat 42 eyes with severe glaucoma that could not be managed successfully by medical therapy and conventional glaucoma surgery. Follow-up ranged from 6 to 36 months (mean, 13 months). The preoperative intraocular pressure (IOP) ranged from 13 to 76 mmHg (mean, 37 mmHg). The postoperative IOP ranged from 1 to 44 mmHg (mean, 17 mmHg), representing an absolute decrease of 20 mmHg, and a mean decrease of 48{\%}. After one or two (7 eyes) treatment sessions, 11 eyes (26{\%}) had an IOP less than 21 mmHg without medications; 21 eyes (50{\%}) had an IOP less than 21 mmHg with medications; 5 eyes (12{\%}) had an IOP of 21 to 25 mmHg with or without medications; and 5 eyes (12{\%}) had an IOP greater than 25 mmHg. Postoperatively, the number of antiglaucoma medications required was reduced from a mean of 2.8 ± 0.13 to a mean of 1.4 ± 0.19. Twenty-three (72{\%}) of 32 patients were able to discontinue carbonic anhydrase inhibitors.",
author = "Zarbin, {M. A.} and Michels, {R. G.} and {De Bustros}, S. and Quigley, {Harry A} and A. Patel",
year = "1988",
language = "English (US)",
volume = "95",
pages = "1639--1648",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Endolaser treatment of the ciliary body for severe glaucoma

AU - Zarbin, M. A.

AU - Michels, R. G.

AU - De Bustros, S.

AU - Quigley, Harry A

AU - Patel, A.

PY - 1988

Y1 - 1988

N2 - Endolaser photocoagulation of the ciliary body was used to treat 42 eyes with severe glaucoma that could not be managed successfully by medical therapy and conventional glaucoma surgery. Follow-up ranged from 6 to 36 months (mean, 13 months). The preoperative intraocular pressure (IOP) ranged from 13 to 76 mmHg (mean, 37 mmHg). The postoperative IOP ranged from 1 to 44 mmHg (mean, 17 mmHg), representing an absolute decrease of 20 mmHg, and a mean decrease of 48%. After one or two (7 eyes) treatment sessions, 11 eyes (26%) had an IOP less than 21 mmHg without medications; 21 eyes (50%) had an IOP less than 21 mmHg with medications; 5 eyes (12%) had an IOP of 21 to 25 mmHg with or without medications; and 5 eyes (12%) had an IOP greater than 25 mmHg. Postoperatively, the number of antiglaucoma medications required was reduced from a mean of 2.8 ± 0.13 to a mean of 1.4 ± 0.19. Twenty-three (72%) of 32 patients were able to discontinue carbonic anhydrase inhibitors.

AB - Endolaser photocoagulation of the ciliary body was used to treat 42 eyes with severe glaucoma that could not be managed successfully by medical therapy and conventional glaucoma surgery. Follow-up ranged from 6 to 36 months (mean, 13 months). The preoperative intraocular pressure (IOP) ranged from 13 to 76 mmHg (mean, 37 mmHg). The postoperative IOP ranged from 1 to 44 mmHg (mean, 17 mmHg), representing an absolute decrease of 20 mmHg, and a mean decrease of 48%. After one or two (7 eyes) treatment sessions, 11 eyes (26%) had an IOP less than 21 mmHg without medications; 21 eyes (50%) had an IOP less than 21 mmHg with medications; 5 eyes (12%) had an IOP of 21 to 25 mmHg with or without medications; and 5 eyes (12%) had an IOP greater than 25 mmHg. Postoperatively, the number of antiglaucoma medications required was reduced from a mean of 2.8 ± 0.13 to a mean of 1.4 ± 0.19. Twenty-three (72%) of 32 patients were able to discontinue carbonic anhydrase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0024260095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024260095&partnerID=8YFLogxK

M3 - Article

C2 - 3068602

AN - SCOPUS:0024260095

VL - 95

SP - 1639

EP - 1648

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 12

ER -